These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33953303)

  • 41. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
    Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
    Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.
    Oldefest M; Düsterhöft S; Desel C; Thysen S; Fink C; Rabe B; Lories R; Grötzinger J; Lorenzen I
    Biochem J; 2015 Jun; 468(3):507-18. PubMed ID: 25846075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The shedding protease ADAM17: Physiology and pathophysiology.
    Zunke F; Rose-John S
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2059-2070. PubMed ID: 28705384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-α in monocytes and colon epithelial cells.
    Tsukamoto H; Tanida S; Ozeki K; Ebi M; Mizoshita T; Shimura T; Mori Y; Kataoka H; Kamiya T; Fukuda S; Higashiyama S; Joh T
    Inflamm Bowel Dis; 2013 Jun; 19(7):1365-73. PubMed ID: 23702712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
    Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
    J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenesis of the ADAM17-phosphatidylserine-binding motif leads to embryonic lethality in mice.
    Veit M; Ahrens B; Seidel J; Sommer A; Bhakdi S; Reiss K
    Life Sci Alliance; 2019 Oct; 2(5):. PubMed ID: 31455669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of ADAM17 and ADAM10 in nasal polyps.
    Bae WY; Park SK; Kim do H; Koh TK; Hur DY; Chueh HW
    Int Forum Allergy Rhinol; 2016 Jul; 6(7):731-6. PubMed ID: 27012683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
    Saftig P; Reiss K
    Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The iRhom2/ADAM17 Axis Attenuates Bacterial Uptake by Phagocytes in a Cell Autonomous Manner.
    Seifert A; Wozniak J; Düsterhöft S; Kasparek P; Sedlacek R; Dreschers S; Orlikowsky TW; Yildiz D; Ludwig A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
    Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
    Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
    Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
    J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Members of the Fibroblast Growth Factor Receptor Superfamily Are Proteolytically Cleaved by Two Differently Activated Metalloproteases.
    Dixit G; Schanz W; Pappas BA; Maretzky T
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endoglycan (PODXL2) is proteolytically processed by ADAM10 (a disintegrin and metalloprotease 10) and controls neurite branching in primary neurons.
    Hsia HE; Tüshaus J; Feng X; Hofmann LI; Wefers B; Marciano DK; Wurst W; Lichtenthaler SF
    FASEB J; 2021 Sep; 35(9):e21813. PubMed ID: 34390512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding.
    Schwarz J; Schmidt S; Will O; Koudelka T; Köhler K; Boss M; Rabe B; Tholey A; Scheller J; Schmidt-Arras D; Schwake M; Rose-John S; Chalaris A
    J Biol Chem; 2014 Jan; 289(5):3080-93. PubMed ID: 24338472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression profile of ADAM10 and ADAM17 in allergic rhinitis.
    Chueh HW; Park SK; Hur DY; Bae WY
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1036-41. PubMed ID: 26250527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
    Maretzky T; Zhou W; Huang XY; Blobel CP
    Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of Kinin B1R Upregulates ADAM17 and Results in ACE2 Shedding in Neurons.
    Parekh RU; Sriramula S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ADAM17-deficiency on microglia but not on macrophages promotes phagocytosis and functional recovery after spinal cord injury.
    Sommer D; Corstjens I; Sanchez S; Dooley D; Lemmens S; Van Broeckhoven J; Bogie J; Vanmierlo T; Vidal PM; Rose-John S; Gou-Fabregas M; Hendrix S
    Brain Behav Immun; 2019 Aug; 80():129-145. PubMed ID: 30851378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
    Ebsen H; Schröder A; Kabelitz D; Janssen O
    PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory bowel disease and ADAM17 deletion.
    Brandl K; Tomisato W; Beutler B
    N Engl J Med; 2012 Jan; 366(2):190; author reply 190. PubMed ID: 22236242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.